ABBVIE INC (ABBV) Fundamental Analysis & Valuation

NYSE:ABBV • US00287Y1091

Current stock price

208.42 USD
-1.84 (-0.88%)
At close:
207.93 USD
-0.49 (-0.24%)
Pre-Market:

This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ABBV Profitability Analysis

1.1 Basic Checks

  • In the past year ABBV was profitable.
  • In the past year ABBV had a positive cash flow from operations.
  • In the past 5 years ABBV has always been profitable.
  • In the past 5 years ABBV always reported a positive cash flow from operatings.
ABBV Yearly Net Income VS EBIT VS OCF VS FCFABBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.12%, ABBV belongs to the top of the industry, outperforming 89.34% of the companies in the same industry.
  • The Return On Invested Capital of ABBV (14.42%) is better than 95.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABBV is significantly below the industry average of 27.73%.
  • The 3 year average ROIC (12.12%) for ABBV is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ABBV Yearly ROA, ROE, ROICABBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • With an excellent Profit Margin value of 6.84%, ABBV belongs to the best of the industry, outperforming 89.53% of the companies in the same industry.
  • ABBV's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ABBV (34.23%) is better than 96.51% of its industry peers.
  • In the last couple of years the Operating Margin of ABBV has grown nicely.
  • ABBV has a better Gross Margin (71.62%) than 81.40% of its industry peers.
  • In the last couple of years the Gross Margin of ABBV has remained more or less at the same level.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
ABBV Yearly Profit, Operating, Gross MarginsABBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. ABBV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABBV is creating some value.
  • ABBV has about the same amout of shares outstanding than it did 1 year ago.
  • ABBV has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ABBV is higher compared to a year ago.
ABBV Yearly Shares OutstandingABBV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABBV Yearly Total Debt VS Total AssetsABBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • ABBV has an Altman-Z score of 2.29. This is not the best score and indicates that ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ABBV's Altman-Z score of 2.29 is fine compared to the rest of the industry. ABBV outperforms 65.31% of its industry peers.
  • ABBV has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as ABBV would need 3.79 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.79, ABBV belongs to the top of the industry, outperforming 91.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.29
ROIC/WACC1.67
WACC8.63%
ABBV Yearly LT Debt VS Equity VS FCFABBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.67, ABBV is not doing good in the industry: 90.31% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.56 indicates that ABBV may have some problems paying its short term obligations.
  • ABBV's Quick ratio of 0.56 is on the low side compared to the rest of the industry. ABBV is outperformed by 90.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
ABBV Yearly Current Assets VS Current LiabilitesABBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. ABBV Growth Analysis

3.1 Past

  • ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • Measured over the past years, ABBV shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.99% on average per year.
  • ABBV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
  • Measured over the past years, ABBV shows a small growth in Revenue. The Revenue has been growing by 5.95% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABBV Yearly Revenue VS EstimatesABBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ABBV Yearly EPS VS EstimatesABBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

8

4. ABBV Valuation Analysis

4.1 Price/Earnings Ratio

  • ABBV is valuated rather expensively with a Price/Earnings ratio of 20.84.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 93.02% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, ABBV is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 14.05, ABBV is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 96.71% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ABBV to the average of the S&P500 Index (38.20), we can say ABBV is valued rather cheaply.
Industry RankSector Rank
PE 20.84
Fwd PE 14.05
ABBV Price Earnings VS Forward Price EarningsABBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ABBV is valued cheaper than 94.38% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ABBV is valued cheaper than 95.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.69
EV/EBITDA 14.73
ABBV Per share dataABBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ABBV has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%

7

5. ABBV Dividend Analysis

5.1 Amount

  • ABBV has a Yearly Dividend Yield of 3.26%.
  • Compared to an average industry Dividend Yield of 0.97, ABBV pays a better dividend. On top of this ABBV pays more dividend than 99.22% of the companies listed in the same industry.
  • ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.26%

5.2 History

  • The dividend of ABBV is nicely growing with an annual growth rate of 6.76%!
  • ABBV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABBV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.76%
Div Incr Years12
Div Non Decr Years12
ABBV Yearly Dividends per shareABBV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by ABBV. This is not a sustainable payout ratio.
  • ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
ABBV Yearly Income VS Free CF VS DividendABBV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
ABBV Dividend Payout.ABBV Dividend Payout, showing the Payout Ratio.ABBV Dividend Payout.PayoutRetained Earnings

ABBV Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

NYSE:ABBV (4/15/2026, 8:04:00 PM)

Premarket: 207.93 -0.49 (-0.24%)

208.42

-1.84 (-0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.21%
Inst Owner Change0.05%
Ins Owners0.05%
Ins Owner Change6.1%
Market Cap368.64B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target256.47 (23.05%)
Short Float %1.14%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 3.26%
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.31%
PT rev (3m)2.69%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-4.28%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE 20.84
Fwd PE 14.05
P/S 6.03
P/FCF 20.69
P/OCF 19.37
P/B N/A
P/tB N/A
EV/EBITDA 14.73
EPS(TTM)10
EY4.8%
EPS(NY)14.83
Fwd EY7.12%
FCF(TTM)10.07
FCFY4.83%
OCF(TTM)10.76
OCFY5.16%
SpS34.58
BVpS-1.85
TBVpS-51.76
PEG (NY)0.43
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.29
F-Score8
WACC8.63%
ROIC/WACC1.67
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / ABBV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to ABBV.


What is the valuation status for ABBV stock?

ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.


What is the profitability of ABBV stock?

ABBVIE INC (ABBV) has a profitability rating of 7 / 10.


What is the valuation of ABBVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 20.84 and the Price/Book (PB) ratio is -112.74.


Is the dividend of ABBVIE INC sustainable?

The dividend rating of ABBVIE INC (ABBV) is 7 / 10 and the dividend payout ratio is 278.48%.